Colorado 2023 Regular Session

Colorado Senate Bill SB260

Introduced
3/31/23  
Refer
3/31/23  
Report Pass
4/13/23  
Refer
4/13/23  
Engrossed
4/18/23  
Refer
4/18/23  
Report Pass
4/25/23  
Refer
4/25/23  
Engrossed
5/8/23  
Engrossed
5/8/23  
Enrolled
5/9/23  

Caption

Individual Access To Publicly Funded Vaccines

Impact

The impact of SB260 on state laws primarily revolves around the regulations governing the administration of publicly funded vaccines. By forbidding practitioners from charging recipients based on their financial situation or requiring extensive documentation, the bill seeks to remove barriers that could deter individuals from receiving vaccines. This could potentially lead to higher vaccination rates, particularly among vulnerable populations, as access mechanisms are put in place that ensure inclusion and equity in public health services.

Summary

Senate Bill 23-260 aims to ensure access to publicly funded vaccines for individuals in Colorado. The bill mandates that practitioners provide these vaccines without imposing conditions based on the individual's ability to pay for administration fees or other documentation. It emphasizes the importance of making vaccines broadly accessible regardless of financial status, reflecting a commitment to public health initiatives designed to improve vaccination rates within the community. The legislation also outlines the requirements for practitioners in terms of transparency and accessibility, including the establishment of electronic appointment scheduling capabilities for interested individuals.

Sentiment

The sentiment surrounding SB260 appears to be largely positive among legislators and public health advocates who view the bill as a vital step toward enhancing public health outcomes. Supporters emphasize its role in protecting populations at risk and facilitating equitable healthcare access. However, there may be some concern from certain healthcare providers, particularly independent pharmacies, who might feel restricted by the requirements imposed by the bill regarding insurance and payment processes.

Contention

Notable points of contention in the discussions surrounding SB260 include the financial implications for practitioners, especially independent pharmacies who may struggle with the regulations on vaccine administration fees compared to larger healthcare institutions. There is a palpable concern about the balance between providing equitable access to vaccines and the financial sustainability of administering those vaccines. The bill's provisions for practitioners to charge administration fees under specific conditions may lead to debates about fairness and the real cost of delivering public health services.

Companion Bills

No companion bills found.

Similar Bills

MT SB112

Revise pharmacist prescribing authority

KS HB2369

Allowing pharmacists to administer certain vaccines to children and adults pursuant to a vaccination protocol.

OR HB3613

Relating to pharmaceutical purchasing; prescribing an effective date.

MS HB1203

Patient's Right to Informed Health Care Choices Act; extend repealer and make certain changes in.

IN HB1327

Health and insurance matters.

GA SB395

Education; the possession of opioid antagonists in schools; authorize

NH HB426

Relative to the regulation of pharmacists-in-charge and pharmacies.

PA HB69

Further providing for title and short title of act, for definitions, for establishment, for restocking and dispensing of cancer drugs, for storage, distribution and fees and for immunity; providing for annual report and for list of approved participating pharmacies; further providing for regulations; and imposing duties on the State Board of Pharmacy.